← Back
Data updated: Mar 10, 2026
AVONDALE PHARMS
Cardiovascular
AVONDALE PHARMS is a specialty pharmaceutical company focused on Cardiovascular.
1998
Since
3
Drugs
-
Trials
28
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MELOXICAM 2024-12-23
Manufacturing (CMC)
MELOXICAM 2024-12-16
Labeling
MELOXICAM 2024-12-12
Labeling
MELOXICAM 2024-11-26
Labeling
MELOXICAM 2024-11-21
Labeling
MELOXICAM 2024-11-21
Labeling
MELOXICAM 2024-11-21
Labeling
MELOXICAM 2024-11-21
Labeling
MELOXICAM 2024-11-21
Labeling
MELOXICAM 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 1998-03-30
- Latest
- 2024-11-21
- Applications
- 4